Akira Teramoto

Dr. Akira Teramoto

Toyama University Hospital, Toyama, Japan
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
SSSatoki Shichijo
Satoki Shichijo
YTYoji Takeuchi
Yoji Takeuchi
YSYuichi Shimodate
Yuichi Shimodate
TYTakeshi Yamashina
Takeshi Yamashina
TYTomoaki Yamasaki
Tomoaki Yamasaki
MKMasayuki Kitano
Masayuki Kitano

2 February 2017 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
JYJuhong Yu
Juhong Yu
HXHong Xia
Hong Xia
ATAkira Teramoto
Akira Teramoto
QNQing‐Qing Ni
Qing‐Qing Ni

1 January 2006 in Neurologia medico-chirurgica
Verified
Journal Article
Open access
YMYasuo Murai
Yasuo Murai
SKShiro Kobayashi
Shiro Kobayashi
KTKojiro Tateyama
Kojiro Tateyama
ATAkira Teramoto
Akira Teramoto
A 72-year-old man presented with a cerebellar vermian tumor manifesting as headaches and vertigo. Angiography disclosed a vascular tumor fed by the superior cerebellar artery and an aneurysm of a primitive trigeminal artery. The patient underwent right occipital craniotomy to remove the highly vascular tumor via an occipital transtentorial approach. Association of a cerebral aneurysm with a hemangioblastoma has been reported previously in only five cases. Only three aneurysms were located on the feeding artery. The aneurysm in this case was not on the feeding artery. Simple coincidence might account for this case.


17 February 2023 in PLOS Digital Health
Verified
Journal Article
Open access
PDF file
KTKazuhisa Tabata
Kazuhisa Tabata
HMHiroshi MIHARA
Hiroshi MIHARA
SNSohachi Nanjo
Sohachi Nanjo
IMIori Motoo
Iori Motoo
TATakayuki Ando
Takayuki Ando
IYIchiro Yasuda
Ichiro Yasuda
IBS is not considered to be an organic disease and usually shows no abnormality on lower gastrointestinal endoscopy, although biofilm formation, dysbiosis, and histological microinflammation have recently been reported in patients with IBS. In this study, we investigated whether an artificial intelligence (AI) colorectal image model can identify minute endoscopic changes, which cannot typically be detected by human investigators, that are associated with IBS. Study subjects were identified based on electronic medical records and categorized as IBS (Group I; n = 11), IBS with predominant constipation (IBS-C; Group C; n = 12), and IBS with predominant diarrhea (IBS-D; Group D; n = 12). The study subjects had no other diseases. Colonoscopy images from IBS patients and from asymptomatic healthy subjects (Group N; n = 88) were obtained. Google Cloud Platform AutoML Vision (single-label classification) was used to construct AI image models to calculate sensitivity, specificity, predictive value, and AUC. A total of 2479, 382, 538, and 484 images were randomly selected for Groups N, I, C and D, respectively. The AUC of the model discriminating between Group N and I was 0.95. Sensitivity, specificity, positive predictive value, and negative predictive value of Group I detection were 30.8%, 97.6%, 66.7%, and 90.2%, respectively. The overall AUC of the model discriminating between Groups N, C, and D was 0.83; sensitivity, specificity, and positive predictive value of Group N were 87.5%, 46.2%, and 79.9%, respectively. Using the image AI model, colonoscopy images of IBS could be discriminated from healthy subjects at AUC 0.95. Prospective studies are needed to further validate whether this externally validated model has similar diagnostic capabilities at other facilities and whether it can be used to determine treatment efficacy.

27 December 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
HFHaruka Fujinami
Haruka Fujinami
ATAkira Teramoto
Akira Teramoto
STSaeko Takahashi
Saeko Takahashi
Takuyaki AndoTakuyaki Ando
Takuyaki Ando
SKShinya Kajiura
Shinya Kajiura
YIYasuda Ichiro
Yasuda Ichiro
This study aimed to assess the utility of the S-O clip during colorectal endoscopic submucosal dissection (ESD). We conducted a retrospective study on 185 patients who underwent colorectal ESD from January 2015 to January 2020. The patients were divided into two groups: before and after the introduction of the S-O clip. Forty-two patients underwent conventional ESD (CO group) and 29 patients underwent ESD using the S-O clip (SO group). We compared the surgery duration, dissection speed, en bloc resection rate, and complication rate between both groups. Compared with the CO group, the SO group had a significantly shorter surgery duration (70.7 ± 37.9 min vs. 51.2 ± 18.6 min; p = 0.017), a significantly higher dissection speed (15.1 ± 9.0 min vs. 26.3 ± 13.8 min; p < 0.001), a significantly higher en bloc resection rate (80.9% vs. 98.8%; p ≤ 0.001), and a significantly lower perforation rate (4.3% vs. 1.3%). In the right colon, the surgery duration was significantly shorter and the dissection speed was significantly higher in the SO group than in the CO group. Moreover, the rate of en bloc resection improved significantly in the right colon. S-O clip-assisted ESD reduces the procedure time and improves the treatment effects, especially in the right colon.